Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2020-05-20
Original SEC Filing: Click here

---

Webplus: CBPO/20200520/6-K_1/2_EX-99.1/000.htm SEC Original: tm2020190d1_ex99-1.htm
China Biologic Reports Financial Results for the First Quarter of 2020 BEIJING, China – May 20, 2020 – First Quarter 2020 Financial Highlights · Total sales · Gross profit Gross margin · Income from operations Operating margin · Non-GAAP adjusted income from operations · Net income attributable to the Company Diluted earnings per share · Non-GAAP adjusted net income attributable

---

---

Webplus: CBPO/20200520/6-K_1/3_EX-99.2/000.htm SEC Original: tm2020190d1_ex99-2.htm
China Biologic First Quarter 2020 Financial Results First Quarter 2020 Financial Performance Total sales Total sales for biopharmaceutical products increased by 31.3% in USD terms, or 35.7% in RMB terms, to $153.0 million in the first quarter of 2020 from $116.5 million in the same quarter of 2019, mainly because of an increase in sales of IVIG products, which was

---

---

Webplus: CBPO/20200520/6-K_1/4_EX-99.3/000.htm SEC Original: tm2020190d1_ex99-3.htm
FOR RELEASE May 20, 2020 China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – May 20, 2020 – China Biologic had no knowledge of the Shuanglin Transaction prior to its public announcement by Shuanglin, and Xinjiang Deyuan did not obtain China Biologic’s consent before entering into such transaction. China Biologic views the Shuanglin Transaction as a

---

---

Webplus: CBPO/20200520/6-K_1/1/000.htm SEC Original: tm2020190d1_6k.htm

---

Company Info:

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2020-05-20CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125